Open AccessP122 (0090) BRENTUXIMAB VEDOTIN PRIOR TO ALLOGENEIC TRANSPLANTATION IN HODGKIN'S LYMPHOMAS REDUCES CHRONIC GVHD WITHOUT WORSENING THE OUTCOME
Publication year - 2018
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000547966.23038.9c
Subject(s) - brentuximab vedotin , medicine , oncology , hodgkin lymphoma , lymphoma